Table 1.
Characteristics of included studies.
References | Country; Centers |
Study
design |
Etiology
(n) |
Sample size |
Patients number,
n, AGA/RGA |
Advocated strategy |
---|---|---|---|---|---|---|
Lockau et al. (22) | Germany; Single center | RC | AS (24); AD (13) | 37 | 12/25 | RGA |
Puri et al. (23) | USA; Multicenter | RC | AS (20); AD (8) | 28 | 24/4 | AGA |
Moptsaris et al. (24) | Germany; Single center | RC | AS (52); AD (9) | 63 | 17/46 | NA |
Eker et al. (14) | France; Multicenter | RPC | AS (121) | 121 | 46/75 | RGA |
Maus et al. (15) | Germany; Multicenter | RPC | AS (144); AD (21) | 171 | 101/70 | RGA |
Yang et al. (12) | China; Multicenter | RC | AS (40); AD (11); CE (8); other (1) | 60 | 31/29 | RGA |
Luu et al. (27) | Vietnam; Single center | RC | NA | 17 | 10/7 | RGA |
Neuberger et al. (13) | Germany; Single center | RPC | NA | 162 | 85/77 | NA |
Park et al. (26) | Korea; Single center | RC | AS (76) | 76 | 56/20 | NA |
Feil et al. (28) | Germany; Multicenter | RPC | NA | 493 | 267/226 | RGA |
Haussen et al. (25) | USA; Multicenter | RPC | AS (289) | 289 | 182/107 | RGA |
RC, retrospective cohort; RPC, retrospective analysis of prospective collected data; AS, arteriosclerosis; AD, arterial dissection; CE, Cardioembolism; AGA, Antegrade approach; RGA, Retrograde approach; NA, not available.